Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) has 84 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 464 | 0.04% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 558,390 | 24.01% | $0.00 |
| 5AM Venture Management, LLC | 31 Dec, 2025 | 0 | 3,457,913 | 705.70% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 331,578 | 139.99% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -48,810 | -1.68% | $0.00 |
| Decheng Capital LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 4,142 | 0.15% | $0.00 |
| Ishara Investments LP | 31 Dec, 2025 | 0 | 1,320,000 | 0.00% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | -113,035 | -5.44% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 141,920 | 26.64% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 251,575 | 17.86% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 576,707 | 0.00% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | 22,300 | 1.53% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 108,067 | 7.93% | $0.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 0 | -116,510 | -20.61% | $0.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 0 | 1,084,356 | 342.55% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 110,000 | 220.00% | $0.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 0 | -1,730,308 | -55.86% | $0.00 |
| Quadrature Capital Ltd | 31 Dec, 2025 | 0 | 76,917 | 126.82% | $0.00 |